These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19815410)

  • 1. Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists II: tuning of receptor selectivity and in vivo efficacy.
    Pippel M; Boyce K; Venkatesan H; Phuong VK; Yan W; Barrett TD; Lagaud G; Li L; Morton MF; Prendergast C; Wu X; Shankley NP; Rabinowitz MH
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6376-8. PubMed ID: 19815410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists I: discovery of CCKR1 selectivity in a previously CCKR2-selective lead series.
    Pippel M; Allison BD; Phuong VK; Li L; Morton MF; Prendergast C; Wu X; Shankley NP; Rabinowitz MH
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6373-5. PubMed ID: 19811913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonists.
    Allison BD; Phuong VK; McAtee LC; Rosen M; Morton M; Prendergast C; Barrett T; Lagaud G; Freedman J; Li L; Wu X; Venkatesan H; Pippel M; Woods C; Rizzolio MC; Hack M; Hoey K; Deng X; King C; Shankley NP; Rabinowitz MH
    J Med Chem; 2006 Oct; 49(21):6371-90. PubMed ID: 17034143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats.
    Cohen H; Kaplan Z; Matar MA; Buriakovsky I; Bourin M; Kotler M
    Depress Anxiety; 2004; 20(3):139-52. PubMed ID: 15487014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protecting-group-free synthesis of a dual CCK1/CCK2 receptor antagonist.
    Liu J; Deng X; Fitzgerald AE; Sales ZS; Venkatesan H; Mani NS
    Org Biomol Chem; 2011 Apr; 9(8):2654-60. PubMed ID: 21365101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potent cholecystokinin-2 receptor antagonists: elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis.
    Rosen MD; Hack MD; Allison BD; Phuong VK; Woods CR; Morton MF; Prendergast CE; Barrett TD; Schubert C; Li L; Wu X; Wu J; Freedman JM; Shankley NP; Rabinowitz MH
    Bioorg Med Chem; 2008 Apr; 16(7):3917-25. PubMed ID: 18289861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation.
    Langmesser S; Cerezo-Guisado MI; Lorenzo MJ; Garcia-Marin LJ; Bragado MJ
    J Cell Biochem; 2007 Mar; 100(4):851-64. PubMed ID: 17226751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of luminal gastrin in the regulation of pancreatic juice secretion in preruminant calves.
    Zabielski R; Normand V; Romé V; Woliński J; Chayvialle JA; Guilloteau P
    Regul Pept; 2004 Jul; 119(3):169-76. PubMed ID: 15120477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parasympathetic non-adrenergic, non-cholinergic transmission in rat parotid glands: effects of cholecystokinin-A and -B receptor antagonists on the secretory response.
    Ekström J; Cevik Aras H
    Regul Pept; 2008 Feb; 146(1-3):278-84. PubMed ID: 18006087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel, achiral 1,3,4-benzotriazepine analogues of 1,4-benzodiazepine-based CCK(2) antagonists that display high selectivity over CCK(1) receptors.
    McDonald IM; Austin C; Buck IM; Dunstone DJ; Griffin E; Harper EA; Hull RA; Kalindjian SB; Linney ID; Low CM; Pether MJ; Spencer J; Wright PT; Adatia T; Bashall A
    J Med Chem; 2006 Apr; 49(7):2253-61. PubMed ID: 16570921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.
    Morton MF; Barrett TD; Yan W; Freedman JM; Lagaud G; Prendergast CE; Moreno V; Pyati J; Figueroa K; Li L; Wu X; Rizzolio M; Breitenbucher JG; McClure K; Shankley NP
    J Pharmacol Exp Ther; 2007 Nov; 323(2):562-9. PubMed ID: 17684117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability.
    Morton MF; Barrett TD; Freedman J; Li L; Rizzolio MC; Prendergast CE; Wu X; Moreno V; Pyati J; Figueroa K; Cagnon L; Lagaud G; Ver Donck L; Ghoos E; Allison B; Rabinowitz MH; Shankley NP
    J Pharmacol Exp Ther; 2011 Jul; 338(1):328-36. PubMed ID: 21493750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthranilic acid based CCK1 receptor antagonists: preliminary investigation on their second "touch point".
    Varnavas A; Lassiani L; Valenta V; Mennuni L; Makovec F; Hadjipavlou-Litina D
    Eur J Med Chem; 2005 Jun; 40(6):563-81. PubMed ID: 15922840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E; Bachy A; Boigegrain R; Brodin R; Cottineau M; Gully D; Herbert JM; Keane P; Labie C; Molimard JC; Olliero D; Oury-Donat F; Petereau C; Prabonnaud V; Rockstroh MP; Schaeffer P; Servant O; Thurneyssen O; Soubrié P; Pascal M; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists.
    Low CM; Buck IM; Cooke T; Cushnir JR; Kalindjian SB; Kotecha A; Pether MJ; Shankley NP; Vinter JG; Wright L
    J Med Chem; 2005 Nov; 48(22):6790-802. PubMed ID: 16250638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists.
    Buck IM; Black JW; Cooke T; Dunstone DJ; Gaffen JD; Griffin EP; Harper EA; Hull RA; Kalindjian SB; Lilley EJ; Linney ID; Low CM; McDonald IM; Pether MJ; Roberts SP; Shankley NP; Shaxted ME; Steel KI; Sykes DA; Tozer MJ; Watt GF; Walker MK; Wright L; Wright PT
    J Med Chem; 2005 Nov; 48(22):6803-12. PubMed ID: 16250639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion.
    McDonald IM; Black JW; Buck IM; Dunstone DJ; Griffin EP; Harper EA; Hull RA; Kalindjian SB; Lilley EJ; Linney ID; Pether MJ; Roberts SP; Shaxted ME; Spencer J; Steel KI; Sykes DA; Walker MK; Watt GF; Wright L; Wright PT; Xun W
    J Med Chem; 2007 Jun; 50(13):3101-12. PubMed ID: 17536796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function.
    Whited KL; Thao D; Lloyd KC; Kopin AS; Raybould HE
    Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G156-62. PubMed ID: 16574983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achiral, selective CCK2 receptor antagonists based on a 1,3,5-benzotriazepine-2,4-dione template.
    Spencer J; Gaffen J; Griffin E; Harper EA; Linney ID; McDonald IM; Roberts SP; Shaxted ME; Adatia T; Bashall A
    Bioorg Med Chem; 2008 Mar; 16(6):2974-83. PubMed ID: 18289857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a "needle" according to the recent homonymous concept.
    Varnavas A; Lassiani L; Valenta V; Berti F; Tontini A; Mennuni L; Makovec F
    Eur J Med Chem; 2004 Jan; 39(1):85-97. PubMed ID: 14987837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.